GUJARAT TERCE LABORATORIES LTD. (GUJTERC) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of GUJARAT TERCE LABORATORIES LTD. stock ₹46.41, price ₹41.13, upside +12.8%, quality 59 out of 100. Rating: undervalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
GUJARAT TERCE LABORATORIES LTD.
GUJTERC · BSESolid company, but only slightly cheap (11% below fair value) and falling price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 22, 2026.
How to read this chart
60‑month range ₹8.19 – ₹89.21 · fair‑value band ₹31.15 – ₹65.90 · the ₹41.13 price screens below the ₹46.41 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 22, 2026.
Every Wednesday you see whether GUJARAT TERCE LABORATORIES is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally.
Show moreShow less
The company's products include branded generic pharmaceutical covering various therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic.
It provides its products in various forms, including tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, and Aziter brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.
Stock analysis
GUJARAT TERCE LABORATORIES LTD. (GUJTERC) currently trades at ₹41.13, while our model-based Fair Value estimate is ₹46.41, implying the stock looks roughly 11% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹58.72 per share, and 14 of the 23 models we run sit above the ₹41.13 price.
Bear case: the Asset-Based group reads lowest at ₹8.37, and 9 of the 23 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹31.15 (bear) to ₹65.90 (bull), the price of ₹41.13 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
GUJARAT TERCE LABORATORIES LTD. reported revenue of ₹475M in FY2026 versus ₹401M in FY2022, a compound +4.3%/yr. Reported net income was ₹22.0M in FY2026, compounding +26.0%/yr from FY2022.
Key figures
Market cap ₹320M (≈ $3.5M) Micro · P/E ratio 15.5 · P/S ratio 0.71 · EPS (TTM) ₹2.65 · Net margin 4.4% · Return on equity 27.2% · Return on assets (EBIT) 5.9% (5-year average) · Operating margin 5.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).
What moves the price
The share trades about 16% below its 52-week high and 33% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −26% fair-value upside, at 13%, GUJTERC screens cheaper than that median.
Fair Value models
All 23 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch GUJTERC, get fair value alerts →
Compare GUJARAT TERCE LABORATORIES LTD. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 611 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Dividend yield by industry
- EV/EBITDA by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $79.11 | $113.53 | +44% | vs GUJTERC |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.00 | ¥51.70 | +10% | vs GUJTERC |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,884.90 | ₹1,982.92 | +5% | vs GUJTERC |
| Haleon plc HLN | $9.07 | $8.47 | −7% | vs GUJTERC |
| Merck KGaA MRK | €146.45 | €108.83 | −26% | vs GUJTERC |
| Galderma Group GALD | CHF 182.85 | CHF 112.84 | −38% | vs GUJTERC |
| Teva Pharmaceutical Industries Limited TEVA | $39.23 | $20.74 | −47% | vs GUJTERC |
| Takeda Pharmaceutical Company TAK | $21.77 | $11.26 | −48% | vs GUJTERC |
| Sandoz Group SDZ | CHF 80.50 | CHF 40.87 | −49% | vs GUJTERC |
| Divi's Laboratories Limited DIVISLAB | ₹11,180.50 | ₹1,566.89 | −86% | vs GUJTERC |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is GUJARAT TERCE LABORATORIES LTD. (GUJTERC) overvalued or undervalued?
What is the fair value of GUJTERC?
What is the quality score of GUJTERC?
What is the price target for GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What is the GUJARAT TERCE LABORATORIES LTD. stock forecast for 2026?
What is the revenue of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What growth is priced into GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What discount rate (WACC) does the fair value of GUJTERC use?
What is a reverse DCF?
How much growth has GUJARAT TERCE LABORATORIES LTD. (GUJTERC) delivered so far?
How fast is the sector of GUJARAT TERCE LABORATORIES LTD. (GUJTERC) growing?
What is the free cash flow yield of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What is the intrinsic value of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
Is GUJARAT TERCE LABORATORIES LTD. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of GUJTERC?
How much is GUJARAT TERCE LABORATORIES LTD. worth?
What do the bullish and bearish scenarios say about GUJTERC?
What is the P/E ratio of GUJTERC?
How solid is the balance sheet of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
How far is GUJTERC from its 52-week high?
Which stocks are comparable to GUJARAT TERCE LABORATORIES LTD.?
Is GUJARAT TERCE LABORATORIES LTD. stock attractive at the current price?
How is the fair value of GUJTERC calculated?
Is it still worth investing in stocks now?
What is the share price of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What should I pay attention to with GUJARAT TERCE LABORATORIES LTD. right now?
Key figures of GUJARAT TERCE LABORATORIES LTD.
How large is the market capitalisation of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What is the P/S ratio of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What are the earnings per share of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What is the net margin of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What is the return on equity of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What is the EBIT return on assets of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
What is the operating margin of GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
How fast is revenue growing at GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
How fast are earnings growing at GUJARAT TERCE LABORATORIES LTD. (GUJTERC)?
How much net debt does GUJARAT TERCE LABORATORIES LTD. (GUJTERC) carry?
Watch GUJARAT TERCE LABORATORIES LTD. in the live analysis
One click puts GUJARAT TERCE LABORATORIES LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.